Development and current clinical application of ventricular assist devices in China  

心室辅助装置在中国的发展和临床应用现状（英文）

作　　者：Yue WU Liang-fan ZHU Yun LUO 

机构地区：[1]School of Mechanical Engineering,Shanghai Jiao Tong University,Shanghai 200240,China

出　　处：《Journal of Zhejiang University-Science B(Biomedicine & Biotechnology)》2017年第11期934-945,共12页浙江大学学报（英文版）B辑（生物医学与生物技术）

基　　金：Project supported by the National Natural Science Foundation of China(No.50821003);the Shanghai Committee of Science and Technology(No.15441905200),China

摘　　要：Heart failure has become one of the biggest threats to human health. Transplantation remains the most effective therapy for heart failure, but because of the shortage of donors, it cannot meet the demand. Ventricular assist devices （VADs） were developed to treat heart failure, and have now been clinically applied worldwide. As the country with the largest population, China is also facing the threat of heart failure. However, the development of VADs in China is very slow and is seldom discussed. This paper first talks about the background for VAD development in China. Then several home-developed VADs in China are introduced. The current clinical application status of VADs in China is also presented. Finally the challenge and opportunity for VAD development in China are discussed.由于人口基数巨大,我国存在大量心力衰竭病人急需治疗,但心脏供体的数量远远无法满足要求。因此,心室辅助装置在我国有广阔的市场需求和应用前景。目前我国心室辅助装置的发展相比发达国家较为滞后,临床应用也数量很少,其高昂的价格是重要制约因素,我国医疗资源的不平衡也是影响因素。我国现已制定各种政策和法规鼓励国产心室辅助装置的发展,也有科研经费和地方财政进行支持。国产心室辅助装置的价格预计会大大低于进口心室辅助装置,一旦投入临床应用,可以使更多的心力衰竭病人受益。

关 键 词：Ventricular assist devices Heart failure Clinical application 

分 类 号：R541.6[医药卫生—心血管疾病]